VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q47810763 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233142.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q47810763‏
024 ‎‡a 0000-0003-1520-093X‏ ‎‡2 orcid‏
024 ‎‡a 6602478015‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q47810763‏
046 ‎‡s 19000000‏
100 0 ‎‡a Jose Sanchez-Moreno‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Jose Sanchez-Moreno‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Jose Sanchez-Moreno‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 1-year follow-up of patients treated with risperidone and topiramate for a manic episode.‏
670 ‎‡a Author's A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.‏
670 ‎‡a Author's A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.‏
670 ‎‡a Author's Acute and continuation risperidone monotherapy in mania.‏
670 ‎‡a Author's Acute and long-term treatment of mania.‏
670 ‎‡a Author's Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study‏
670 ‎‡a Author's Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder‏
670 ‎‡a Author's Adjunctive topiramate in bipolar II disorder‏
670 ‎‡a Author's An open-label study of amisulpride in the treatment of mania‏
670 ‎‡a Author's Analog isolated electronic dynamometer based on a magnetoresistive current sensor.‏
670 ‎‡a Author's Behavioural activation training for depression‏
670 ‎‡a Author's [Bipolar disorder, cognitive functioning and hypothalamic-pituitary-thyroid axis]‏
670 ‎‡a Author's Bipolar disorder preceded by substance abuse: A different phenotype with not so poor outcome?‏
670 ‎‡a Author's Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?‏
670 ‎‡a Author's Clasificación Internacional del Funcionamiento, la Discapacidad y la Salud (CIF): aplicabilidad y utilidad en la práctica clínica‏
670 ‎‡a Author's Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.‏
670 ‎‡a Author's Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients.‏
670 ‎‡a Author's Clinical and therapeutic implications of predominant polarity in bipolar disorder.‏
670 ‎‡a Author's Clinical correlates of first-episode polarity in bipolar disorder.‏
670 ‎‡a Author's Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study‏
670 ‎‡a Author's Clinical predictors of functional outcome of bipolar patients in remission.‏
670 ‎‡a Author's Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.‏
670 ‎‡a Author's Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results‏
670 ‎‡a Author's Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.‏
670 ‎‡a Author's Cognitive impairment in bipolar II disorder.‏
670 ‎‡a Author's Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.‏
670 ‎‡a Author's Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine‏
670 ‎‡a Author's Cross validation with the mood disorder questionnaire‏
670 ‎‡a Author's Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).‏
670 ‎‡a Author's Depression subtypes in bipolar I and II disorders.‏
670 ‎‡a Author's Depressive disorders and suicide: Epidemiology, risk factors, and burden‏
670 ‎‡a Author's Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.‏
670 ‎‡a Author's Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment?‏
670 ‎‡a Author's Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.‏
670 ‎‡a Author's e-HCL-32: a useful, valid and user friendly tool in the screening of bipolar II disorder‏
670 ‎‡a Author's Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.‏
670 ‎‡a Author's [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]‏
670 ‎‡a Author's Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis‏
670 ‎‡a Author's Ethical considerations for precision psychiatry: A roadmap for research and clinical practice‏
670 ‎‡a Author's Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?‏
670 ‎‡a Author's Evaluation of Patient Satisfaction in a State Reference Center of Bipolar Disorder‏
670 ‎‡a Author's Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review‏
670 ‎‡a Author's Factors associated with initial treatment response with antidepressants in bipolar disorder‏
670 ‎‡a Author's Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables‏
670 ‎‡a Author's Family functioning in bipolar disorder: Characteristics, congruity between patients and relatives, and clinical correlates.‏
670 ‎‡a Author's Functional impairment and previous suicide attempts in bipolar disorder.‏
670 ‎‡a Author's Functional Impairment in Patients with Remitted Bipolar Disorder‏
670 ‎‡a Author's Functional outcome in bipolar disorder: the role of clinical and cognitive factors.‏
670 ‎‡a Author's Functioning and disability in bipolar disorder: an extensive review‏
670 ‎‡a Author's Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity‏
670 ‎‡a Author's Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.‏
670 ‎‡a Author's High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment.‏
670 ‎‡a Author's Identifying and improving non-adherence in bipolar disorders.‏
670 ‎‡a Author's Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients.‏
670 ‎‡a Author's Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial‏
670 ‎‡a Author's Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder‏
670 ‎‡a Author's Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies‏
670 ‎‡a Author's Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder‏
670 ‎‡a Author's Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.‏
670 ‎‡a Author's Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders‏
670 ‎‡a Author's Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.‏
670 ‎‡a Author's Mania and depression. Mixed, not stirred.‏
670 ‎‡a Author's Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study.‏
670 ‎‡a Author's Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.‏
670 ‎‡a Author's Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use.‏
670 ‎‡a Author's Neurocognitive endophenotypes‏
670 ‎‡a Author's Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review.‏
670 ‎‡a Author's Neurocognitive impairment in bipolar patients with and without history of psychosis.‏
670 ‎‡a Author's Neuropsychological disturbances and cerebral blood flow in bipolar disorder‏
670 ‎‡a Author's Neuropsychological performance in depressed and euthymic bipolar patients.‏
670 ‎‡a Author's Origins of psychiatric hospitalization in medieval Spain‏
670 ‎‡a Author's Predominant polarity and temperament in bipolar and unipolar affective disorders‏
670 ‎‡a Author's Predominant polarity in bipolar disorder: Diagnostic implications‏
670 ‎‡a Author's Process of adaptation to Spanish of the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Scale. Self applied version (TEMPS-A)‏
670 ‎‡a Author's Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis.‏
670 ‎‡a Author's Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction.‏
670 ‎‡a Author's Psychoeducation in bipolar patients with comorbid personality disorders‏
670 ‎‡a Author's Psychometric properties of the well-being index‏
670 ‎‡a Author's Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder.‏
670 ‎‡a Author's Psychosocial interventions in bipolar disorder: what, for whom, and when.‏
670 ‎‡a Author's Psychotic versus non-psychotic bipolar II disorder.‏
670 ‎‡a Author's Relevance of family history of suicide in the long-term outcome of bipolar disorders.‏
670 ‎‡a Author's Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode‏
670 ‎‡a Author's Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocols‏
670 ‎‡a Author's Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population‏
670 ‎‡a Author's Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels‏
670 ‎‡a Author's Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.‏
670 ‎‡a Author's Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability‏
670 ‎‡a Author's Suicide mortality in Olot from 1936 until 2000‏
670 ‎‡a Author's The clinical implications of cognitive impairment and allostatic load in bipolar disorder‏
670 ‎‡a Author's The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder‏
670 ‎‡a Author's The role and impact of contextual factors on functioning in patients with bipolar disorder‏
670 ‎‡a Author's The role of family interventions in bipolar disorder: A systematic review‏
670 ‎‡a Author's The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.‏
670 ‎‡a Author's The symptom structure of bipolar acute episodes: in search for the mixing link.‏
670 ‎‡a Author's Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome.‏
670 ‎‡a Author's Treatment guidelines for bipolar disorder: a critical review.‏
670 ‎‡a Author's Treatment nonadherence and neurocognitive impairment in bipolar disorder.‏
670 ‎‡a Author's Treatment of Functional Impairment in Patients with Bipolar Disorder‏
670 ‎‡a Author's Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.‏
670 ‎‡a Author's Treatment-resistant bipolar depression: towards a new definition.‏
670 ‎‡a Author's Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options‏
670 ‎‡a Author's Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study‏
670 ‎‡a Author's Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.‏
670 ‎‡a Author's Vigencia del tratamiento con litio‏
670 ‎‡a Author's Vortioxetine: A new alternative for the treatment of major depressive disorder‏
670 ‎‡a Author's Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.‏
670 ‎‡a Author's What really matters to bipolar patients' caregivers: sources of family burden.‏
670 ‎‡a Author's Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania?‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/NUKAT|n 2017046962‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/BNE|XX4615594‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/169086774‏
909 ‎‡a (scopus) 6602478015‏ ‎‡9 1‏
909 ‎‡a (orcid) 000000031520093x‏ ‎‡9 1‏
919 ‎‡a psychometricpropertiesofthewellbeingindex‏ ‎‡A Psychometric properties of the well-being index‏ ‎‡9 1‏
919 ‎‡a psychoeducationinbipolardisorderwithasimplesmartphoneapplicationfeasibilityacceptabilityandsatisfaction‏ ‎‡A Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction.‏ ‎‡9 1‏
919 ‎‡a psychoeducationforbipolar2disorderanexploratory5yearoutcomesubanalysis‏ ‎‡A Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis.‏ ‎‡9 1‏
919 ‎‡a processofadaptationtospanishofthetemperamentevaluationofmemphispisaparisand3diegoscaleselfappliedversiontempsa‏ ‎‡A Process of adaptation to Spanish of the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Scale. Self applied version (TEMPS-A)‏ ‎‡9 1‏
919 ‎‡a predominantpolarityinbipolardisorderdiagnosticimplications‏ ‎‡A Predominant polarity in bipolar disorder: Diagnostic implications‏ ‎‡9 1‏
919 ‎‡a predominantpolarityandtemperamentinbipolarandunipolaraffectivedisorders‏ ‎‡A Predominant polarity and temperament in bipolar and unipolar affective disorders‏ ‎‡9 1‏
919 ‎‡a originsofpsychiatrichospitalizationinmedievalspain‏ ‎‡A Origins of psychiatric hospitalization in medieval Spain‏ ‎‡9 1‏
919 ‎‡a neuropsychologicalperformanceindepressedandeuthymicbipolarpatients‏ ‎‡A Neuropsychological performance in depressed and euthymic bipolar patients.‏ ‎‡9 1‏
919 ‎‡a neuropsychologicaldisturbancesandcerebralbloodflowinbipolardisorder‏ ‎‡A Neuropsychological disturbances and cerebral blood flow in bipolar disorder‏ ‎‡9 1‏
919 ‎‡a neurocognitiveimpairmentinbipolarpatientswithandwithouthistoryofpsychosis‏ ‎‡A Neurocognitive impairment in bipolar patients with and without history of psychosis.‏ ‎‡9 1‏
919 ‎‡a neurocognitiveendophenotypesendophenocognitypesfromstudiesofrelativesofbipolardisordersubjectsasystematicreview‏ ‎‡A Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review.‏ ‎‡9 1‏
919 ‎‡a neurocognitiveendophenotypes‏ ‎‡A Neurocognitive endophenotypes‏ ‎‡9 1‏
919 ‎‡a neurocognitivedysfunctionsineuthymicbipolarpatientswithandwithoutpriorhistoryofalcoholuse‏ ‎‡A Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use.‏ ‎‡9 1‏
919 ‎‡a selfmonitoringandpsychoeducationinbipolarpatientswithasmartphoneapplicationsimpleprojectdesigndevelopmentandstudiesprotocols‏ ‎‡A Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocols‏ ‎‡9 1‏
919 ‎‡a neurocognitiveandclinicalpredictorsoffunctionaloutcomeinpatientswithschizophreniaandbipolar1disorderat1yearfollowup‏ ‎‡A Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.‏ ‎‡9 1‏
919 ‎‡a manualmotorspeeddysfunctionasaneurocognitiveendophenotypeineuthymicbipolardisorderpatientsandtheirhealthyrelativesevidencefroma5yearfollowupstudy‏ ‎‡A Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study.‏ ‎‡9 1‏
919 ‎‡a spanishvalidationofthebarcelonatempsaquestionnaireinpatientswithbipolardisorderandgeneralpopulation‏ ‎‡A Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population‏ ‎‡9 1‏
919 ‎‡a maniaanddepressionmixednotstirred‏ ‎‡A Mania and depression. Mixed, not stirred.‏ ‎‡9 1‏
919 ‎‡a lowerrateofdepressiveswitchfollowingantimanictreatmentwith2generationantipsychoticsversushaloperidol‏ ‎‡A Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.‏ ‎‡9 1‏
919 ‎‡a longtermmentalhealthresourceutilizationandcostofcarefollowinggrouppsychoeducationorunstructuredgroupsupportforbipolardisorders‏ ‎‡A Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders‏ ‎‡9 1‏
919 ‎‡a longterm3yearneurocognitiveeffectivenessofantipsychoticmedicationsin1episodenonaffectivepsychosisarandomizedcomparisonofhaloperidololanzapineandrisperidone‏ ‎‡A Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.‏ ‎‡9 1‏
919 ‎‡a lifetimepsychoticsymptomssubthresholddepressionandcognitiveimpairmentasbarrierstofunctionalrecoveryinpatientswithbipolardisorder‏ ‎‡A Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder‏ ‎‡9 1‏
919 ‎‡a inverseanddirectcancercomorbidityinpeoplewithcentralnervoussystemdisordersametaanalysisofcancerincidencein577013participantsof50observationalstudies‏ ‎‡A Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies‏ ‎‡9 1‏
919 ‎‡a improvingfunctioningqualityoflifeandwellbeinginpatientswithbipolardisorder‏ ‎‡A Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder‏ ‎‡9 1‏
919 ‎‡a impactofcaregivergrouppsychoeducationonthecourseandoutcomeofbipolarpatientsinremissionarandomizedcontrolledtrial‏ ‎‡A Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial‏ ‎‡9 1‏
919 ‎‡a impactofapsychoeducationalfamilyinterventiononcaregiversofstabilizedbipolarpatients‏ ‎‡A Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients.‏ ‎‡9 1‏
919 ‎‡a identifyingandimprovingnonadherenceinbipolardisorders‏ ‎‡A Identifying and improving non-adherence in bipolar disorders.‏ ‎‡9 1‏
919 ‎‡a highcognitivereserveinbipolardisordersasamoderatorofneurocognitiveimpairment‏ ‎‡A High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment.‏ ‎‡9 1‏
919 ‎‡a stabilizingthestabilizergrouppsychoeducationenhancesthestabilityofserumlithiumlevels‏ ‎‡A Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels‏ ‎‡9 1‏
919 ‎‡a subsyndromaldepressivesymptomsinpatientswithbipolarandunipolardisorderduringclinicalremission‏ ‎‡A Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.‏ ‎‡9 1‏
919 ‎‡a subthresholdsymptomsinbipolardisorderimpactonneurocognitionqualityoflifeanddisability‏ ‎‡A Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability‏ ‎‡9 1‏
919 ‎‡a suicidemortalityinolotfrom1936until‏ ‎‡A Suicide mortality in Olot from 1936 until 2000‏ ‎‡9 1‏
919 ‎‡a clinicalimplicationsofcognitiveimpairmentandallostaticloadinbipolardisorder‏ ‎‡A The clinical implications of cognitive impairment and allostatic load in bipolar disorder‏ ‎‡9 1‏
919 ‎‡a impactofrepeatedmanicepisodesandexecutivedysfunctiononworkadjustmentinbipolardisorder‏ ‎‡A The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder‏ ‎‡9 1‏
919 ‎‡a roleandimpactofcontextualfactorsonfunctioninginpatientswithbipolardisorder‏ ‎‡A The role and impact of contextual factors on functioning in patients with bipolar disorder‏ ‎‡9 1‏
919 ‎‡a grouppsychoeducationforstabilisedbipolardisorders5yearoutcomeofarandomisedclinicaltrial‏ ‎‡A Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.‏ ‎‡9 1‏
919 ‎‡a genderdifferencesinacohortstudyof604bipolarpatientstheroleofpredominantpolarity‏ ‎‡A Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity‏ ‎‡9 1‏
919 ‎‡a functioninganddisabilityinbipolardisorderanextensivereview‏ ‎‡A Functioning and disability in bipolar disorder: an extensive review‏ ‎‡9 1‏
919 ‎‡a functionaloutcomeinbipolardisordertheroleofclinicalandcognitivefactors‏ ‎‡A Functional outcome in bipolar disorder: the role of clinical and cognitive factors.‏ ‎‡9 1‏
919 ‎‡a roleoffamilyinterventionsinbipolardisorderasystematicreview‏ ‎‡A The role of family interventions in bipolar disorder: A systematic review‏ ‎‡9 1‏
919 ‎‡a functionalimpairmentinpatientswithremittedbipolardisorder‏ ‎‡A Functional Impairment in Patients with Remitted Bipolar Disorder‏ ‎‡9 1‏
919 ‎‡a symptomstructureofbipolaracuteepisodesinsearchforthemixinglink‏ ‎‡A The symptom structure of bipolar acute episodes: in search for the mixing link.‏ ‎‡9 1‏
919 ‎‡a functionalimpairmentandprevioussuicideattemptsinbipolardisorder‏ ‎‡A Functional impairment and previous suicide attempts in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a familyfunctioninginbipolardisordercharacteristicscongruitybetweenpatientsandrelativesandclinicalcorrelates‏ ‎‡A Family functioning in bipolar disorder: Characteristics, congruity between patients and relatives, and clinical correlates.‏ ‎‡9 1‏
919 ‎‡a towardsaclinicalstagingforbipolardisorderdefiningpatientsubtypesbasedonfunctionaloutcome‏ ‎‡A Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome.‏ ‎‡9 1‏
919 ‎‡a treatmentguidelinesforbipolardisorderacriticalreview‏ ‎‡A Treatment guidelines for bipolar disorder: a critical review.‏ ‎‡9 1‏
919 ‎‡a treatmentnonadherenceandneurocognitiveimpairmentinbipolardisorder‏ ‎‡A Treatment nonadherence and neurocognitive impairment in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a treatmentoffunctionalimpairmentinpatientswithbipolardisorder‏ ‎‡A Treatment of Functional Impairment in Patients with Bipolar Disorder‏ ‎‡9 1‏
919 ‎‡a factorsassociatedwithpoorfunctionaloutcomeinbipolardisordersociodemographicclinicalandneurocognitivevariables‏ ‎‡A Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables‏ ‎‡9 1‏
919 ‎‡a treatmentofneurocognitivesymptomsinunipolardepressionasystematicreviewandfutureperspectives‏ ‎‡A Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.‏ ‎‡9 1‏
919 ‎‡a factorsassociatedwithinitialtreatmentresponsewithantidepressantsinbipolardisorder‏ ‎‡A Factors associated with initial treatment response with antidepressants in bipolar disorder‏ ‎‡9 1‏
919 ‎‡a evidencebasedresearchontheefficacyofpsychologicinterventionsinbipolardisordersacriticalreview‏ ‎‡A Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review‏ ‎‡9 1‏
919 ‎‡a evaluationofpatientsatisfactioninastatereferencecenterofbipolardisorder‏ ‎‡A Evaluation of Patient Satisfaction in a State Reference Center of Bipolar Disorder‏ ‎‡9 1‏
919 ‎‡a treatmentresistantbipolardepressiontowardsanewdefinition‏ ‎‡A Treatment-resistant bipolar depression: towards a new definition.‏ ‎‡9 1‏
919 ‎‡a treatmentstrategiesaccordingtoclinicalfeaturesinanaturalisticcohortstudyofbipolarpatientsaprincipalcomponentanalysisoflifetimepharmacologicalandbiophysictreatmentoptions‏ ‎‡A Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options‏ ‎‡9 1‏
919 ‎‡a validationoftheportugueseversionofthelithiumattitudesquestionnairelaqinbipolarpatientstreatedwithlithiumcrossoverstudy‏ ‎‡A Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study‏ ‎‡9 1‏
919 ‎‡a validityandreliabilityofthefunctioningassessmentshorttestfastinbipolardisorder‏ ‎‡A Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a ethicalquestionsinhumanclinicalpsychopharmacologyshouldthefocusbeonplaceboadministration‏ ‎‡A Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?‏ ‎‡9 1‏
919 ‎‡a vigenciadeltratamientoconlitio‏ ‎‡A Vigencia del tratamiento con litio‏ ‎‡9 1‏
919 ‎‡a ethicalconsiderationsforprecisionpsychiatryaroadmapforresearchandclinicalpractice‏ ‎‡A Ethical considerations for precision psychiatry: A roadmap for research and clinical practice‏ ‎‡9 1‏
919 ‎‡a efficacyofmodernantipsychoticsinplacebocontrolledtrialsinbipolardepressionametaanalysis‏ ‎‡A Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a efficacyandsafetyoflongactinginjectablerisperidoneinmaintenancephaseofbipolarandschizoaffectivedisorder‏ ‎‡A [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]‏ ‎‡9 1‏
919 ‎‡a vortioxetineanewalternativeforthetreatmentofmajordepressivedisorder‏ ‎‡A Vortioxetine: A new alternative for the treatment of major depressive disorder‏ ‎‡9 1‏
919 ‎‡a weightgaininbipolardisorderpharmacologicaltreatmentasacontributingfactor‏ ‎‡A Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.‏ ‎‡9 1‏
919 ‎‡a whatreallymatterstobipolarpatientscaregiverssourcesoffamilyburden‏ ‎‡A What really matters to bipolar patients' caregivers: sources of family burden.‏ ‎‡9 1‏
919 ‎‡a whydocliniciansmaintainantidepressantsinsomepatientswithacutemania‏ ‎‡A Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania?‏ ‎‡9 1‏
919 ‎‡a effectsonweightandoutcomeoflongtermolanzapinetopiramatecombinationtreatmentinbipolardisorder‏ ‎‡A Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a ehcl32ausefulvalidanduserfriendlytoolinthescreeningofbipolar2disorder‏ ‎‡A e-HCL-32: a useful, valid and user friendly tool in the screening of bipolar II disorder‏ ‎‡9 1‏
919 ‎‡a dopatientswithbipolardisorderandsubsyndromalsymptomsbenefitfromfunctionalremediationa12monthfollowupstudy‏ ‎‡A Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.‏ ‎‡9 1‏
919 ‎‡a docognitivecomplaintsineuthymicbipolarpatientsreflectobjectivecognitiveimpairment‏ ‎‡A Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment?‏ ‎‡9 1‏
919 ‎‡a psychoeducationinbipolarpatientswithcomorbidpersonalitydisorders‏ ‎‡A Psychoeducation in bipolar patients with comorbid personality disorders‏ ‎‡9 1‏
919 ‎‡a differentialoutcomeofbipolarpatientsreceivingantidepressantmonotherapyversuscombinationwithanantimanicdrug‏ ‎‡A Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.‏ ‎‡9 1‏
919 ‎‡a depressivedisordersandsuicideepidemiologyriskfactorsandburden‏ ‎‡A Depressive disorders and suicide: Epidemiology, risk factors, and burden‏ ‎‡9 1‏
919 ‎‡a depressionsubtypesinbipolar1and2disorders‏ ‎‡A Depression subtypes in bipolar I and II disorders.‏ ‎‡9 1‏
919 ‎‡a crossvalidationwiththemooddisorderquestionnairemdqofaninstrumentforthedetectionofhypomaniainspanishthe32itemhypomaniasymptomchecklisthcl32‏ ‎‡A Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).‏ ‎‡9 1‏
919 ‎‡a crossvalidationwiththemooddisorderquestionnaire‏ ‎‡A Cross validation with the mood disorder questionnaire‏ ‎‡9 1‏
919 ‎‡a comparisonofrapidcyclingandnonrapidcyclingbipolar1manicpatientsduringtreatmentwitholanzapine‏ ‎‡A Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentineuthymicbipolarpatientsimplicationsforclinicalandfunctionaloutcome‏ ‎‡A Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentinbipolar2disorder‏ ‎‡A Cognitive impairment in bipolar II disorder.‏ ‎‡9 1‏
919 ‎‡a cognitiveimpairmentinbipolardisordertreatmentandpreventionstrategies‏ ‎‡A Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.‏ ‎‡9 1‏
919 ‎‡a cognitivefunctioninginbipolarpatientsreceivinglamotriginepreliminaryresults‏ ‎‡A Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results‏ ‎‡9 1‏
919 ‎‡a cognitivefunctionacrossmanicorhypomanicdepressedandeuthymicstatesinbipolardisorder‏ ‎‡A Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a clinicalpredictorsoffunctionaloutcomeofbipolarpatientsinremission‏ ‎‡A Clinical predictors of functional outcome of bipolar patients in remission.‏ ‎‡9 1‏
919 ‎‡a clinicalimplicationsofpredominantpolarityandthepolarityindexinbipolardisorderanaturalisticstudy‏ ‎‡A Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study‏ ‎‡9 1‏
919 ‎‡a clinicalcorrelatesof1episodepolarityinbipolardisorder‏ ‎‡A Clinical correlates of first-episode polarity in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a clinicalandtherapeuticimplicationsofpredominantpolarityinbipolardisorder‏ ‎‡A Clinical and therapeutic implications of predominant polarity in bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a clinicalandprognosticimplicationsofseasonalpatterninbipolardisordera10yearfollowupof302patients‏ ‎‡A Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients.‏ ‎‡9 1‏
919 ‎‡a clinicalandneurocognitivepredictorsoffunctionaloutcomeinbipolareuthymicpatientsalongtermfollowupstudy‏ ‎‡A Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.‏ ‎‡9 1‏
919 ‎‡a clasificacioninternacionaldelfuncionamientoladiscapacidadylasaludcifaplicabilidadyutilidadenlapracticaclinica‏ ‎‡A Clasificación Internacional del Funcionamiento, la Discapacidad y la Salud (CIF): aplicabilidad y utilidad en la práctica clínica‏ ‎‡9 1‏
919 ‎‡a bipolar1patientswithandwithoutahistoryofpsychoticsymptomsdotheydifferintheircognitivefunctioning‏ ‎‡A Bipolar I patients with and without a history of psychotic symptoms: do they differ in their cognitive functioning?‏ ‎‡9 1‏
919 ‎‡a bipolardisorderprecededbysubstanceabuseadifferentphenotypewithnotsopooroutcome‏ ‎‡A Bipolar disorder preceded by substance abuse: A different phenotype with not so poor outcome?‏ ‎‡9 1‏
919 ‎‡a bipolardisordercognitivefunctioningandhypothalamicpituitarythyroidaxis‏ ‎‡A [Bipolar disorder, cognitive functioning and hypothalamic-pituitary-thyroid axis]‏ ‎‡9 1‏
919 ‎‡a behaviouralactivationtrainingfordepression‏ ‎‡A Behavioural activation training for depression‏ ‎‡9 1‏
919 ‎‡a analogisolatedelectronicdynamometerbasedonamagnetoresistivecurrentsensor‏ ‎‡A Analog isolated electronic dynamometer based on a magnetoresistive current sensor.‏ ‎‡9 1‏
919 ‎‡a openlabelstudyofamisulprideinthetreatmentofmania‏ ‎‡A An open-label study of amisulpride in the treatment of mania‏ ‎‡9 1‏
919 ‎‡a adjunctivetopiramateinbipolar2disorder‏ ‎‡A Adjunctive topiramate in bipolar II disorder‏ ‎‡9 1‏
919 ‎‡a adaptationandvalidationofthespanishversionofthemooddisorderquestionnaireforthedetectionofbipolardisorder‏ ‎‡A Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder‏ ‎‡9 1‏
919 ‎‡a adaptationandvalidationoftheportugueseversionofthelithiumknowledgetestlktofbipolarpatientstreatedwithlithiumcrossoverstudy‏ ‎‡A Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study‏ ‎‡9 1‏
919 ‎‡a acuteandlongtermtreatmentofmania‏ ‎‡A Acute and long-term treatment of mania.‏ ‎‡9 1‏
919 ‎‡a acuteandcontinuationrisperidonemonotherapyinmania‏ ‎‡A Acute and continuation risperidone monotherapy in mania.‏ ‎‡9 1‏
919 ‎‡a doubleblindrandomizedplacebocontrolledprophylaxisstudyofadjunctivegabapentinforbipolardisorder‏ ‎‡A A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.‏ ‎‡9 1‏
919 ‎‡a caseofmanicepisodeduringtreatmentwith5fluorouracilepirubicinandcyclophosphamideforbreastcancer‏ ‎‡A A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.‏ ‎‡9 1‏
919 ‎‡a 1yearfollowupofpatientstreatedwithrisperidoneandtopiramateforamanicepisode‏ ‎‡A 1-year follow-up of patients treated with risperidone and topiramate for a manic episode.‏ ‎‡9 1‏
919 ‎‡a switchfromconventionaltoatypicalantipsychotictreatmentshouldnotbebasedexclusivelyonthepresenceofcognitivedeficitsapilotstudyinindividualswithschizophrenia‏ ‎‡A The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.‏ ‎‡9 1‏
919 ‎‡a screeningforbipolardisorderinaspanishsampleofoutpatientswithcurrentmajordepressiveepisode‏ ‎‡A Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode‏ ‎‡9 1‏
919 ‎‡a relevanceoffamilyhistoryofsuicideinthelongtermoutcomeofbipolardisorders‏ ‎‡A Relevance of family history of suicide in the long-term outcome of bipolar disorders.‏ ‎‡9 1‏
919 ‎‡a psychoticversusnonpsychoticbipolar2disorder‏ ‎‡A Psychotic versus non-psychotic bipolar II disorder.‏ ‎‡9 1‏
919 ‎‡a psychosocialinterventionsinbipolardisorderwhatforwhomandwhen‏ ‎‡A Psychosocial interventions in bipolar disorder: what, for whom, and when.‏ ‎‡9 1‏
919 ‎‡a psychometricpropertiesofthewellbeingindexwho5spanishversioninasampleofeuthymicpatientswithbipolardisorder‏ ‎‡A Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder.‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2000‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NII|DA16330503‏
996 ‎‡2 ISNI|0000000396632119‏
996 ‎‡2 DNB|123680379‏
996 ‎‡2 LC|n 81083880‏
996 ‎‡2 LC|ns2014000867‏
996 ‎‡2 DE633|pe30108481‏
996 ‎‡2 DBC|87097991617463‏
996 ‎‡2 BNC|981058513919606706‏
996 ‎‡2 ISNI|0000000120981430‏
996 ‎‡2 ISNI|000000000249077X‏
996 ‎‡2 LC|n 2002037455‏
996 ‎‡2 LC|no2006068928‏
996 ‎‡2 ISNI|0000000061150927‏
996 ‎‡2 BNE|XX970374‏
996 ‎‡2 BNE|XX1444186‏
996 ‎‡2 PTBNP|137692‏
996 ‎‡2 SUDOC|077340280‏
996 ‎‡2 BNE|XX1206376‏
996 ‎‡2 SUDOC|060260157‏
996 ‎‡2 BNE|XX1650976‏
996 ‎‡2 BNE|XX1182980‏
996 ‎‡2 BNCHL|10000000000000000866674‏
996 ‎‡2 BNC|981058614834306706‏
996 ‎‡2 PTBNP|177996‏
996 ‎‡2 ISNI|000000008017684X‏
996 ‎‡2 PLWABN|9810681085105606‏
996 ‎‡2 ISNI|0000000060970843‏
996 ‎‡2 BNE|XX1648925‏
996 ‎‡2 PTBNP|1489769‏
996 ‎‡2 LC|n 2019182549‏
996 ‎‡2 BNE|XX1053553‏
996 ‎‡2 DNB|1157747930‏
996 ‎‡2 BIBSYS|9021710‏
996 ‎‡2 LC|n 2004099908‏
996 ‎‡2 BIBSYS|1581514958509‏
996 ‎‡2 ISNI|0000000039250665‏
996 ‎‡2 ISNI|000000011905690X‏
996 ‎‡2 BNE|XX1211456‏
996 ‎‡2 BNCHL|10000000000000000119195‏
996 ‎‡2 BNC|981058528418606706‏
996 ‎‡2 BNE|XX5478002‏
996 ‎‡2 BNC|981058518412306706‏
996 ‎‡2 DNB|134134796‏
996 ‎‡2 J9U|987007429038205171‏
996 ‎‡2 ISNI|0000000027820712‏
996 ‎‡2 DNB|1158090153‏
996 ‎‡2 ISNI|0000000059286884‏
996 ‎‡2 BAV|495_190828‏
996 ‎‡2 DNB|174210264‏
996 ‎‡2 LC|n 95081889‏
996 ‎‡2 LC|n 96039143‏
996 ‎‡2 DNB|142169633‏
996 ‎‡2 BNF|14582913‏
996 ‎‡2 NTA|315597704‏
996 ‎‡2 ISNI|0000000060407575‏
996 ‎‡2 LC|no2003108617‏
996 ‎‡2 BNE|XX1483498‏
996 ‎‡2 LC|n 00090223‏
996 ‎‡2 BNE|XX6252269‏
996 ‎‡2 LC|no2010169593‏
996 ‎‡2 BNE|XX1380286‏
996 ‎‡2 CAOONL|ncf11258494‏
996 ‎‡2 BNE|XX859215‏
996 ‎‡2 LC|nr 00010493‏
996 ‎‡2 ISNI|0000000377546530‏
996 ‎‡2 BNE|XX1363729‏
996 ‎‡2 LC|nb2006009032‏
996 ‎‡2 BNE|XX1079508‏
996 ‎‡2 ISNI|0000000072082907‏
996 ‎‡2 BNC|981058612360506706‏
996 ‎‡2 BNE|XX1690302‏
996 ‎‡2 BNE|XX1005184‏
996 ‎‡2 LC|no2019181810‏
996 ‎‡2 PTBNP|1864981‏
996 ‎‡2 LC|nr 92040384‏
996 ‎‡2 SUDOC|158413180‏
996 ‎‡2 LC|no2001010856‏
996 ‎‡2 NKC|mzk2005273175‏
996 ‎‡2 BNC|981058518060106706‏
996 ‎‡2 DNB|105618017X‏
996 ‎‡2 BNE|XX1728816‏
996 ‎‡2 LC|no2007155802‏
996 ‎‡2 ISNI|0000000045531201‏
996 ‎‡2 LC|no2022053734‏
996 ‎‡2 LC|no2018053956‏
996 ‎‡2 DE633|pe30033375‏
996 ‎‡2 PTBNP|1810578‏
996 ‎‡2 ISNI|0000000069991376‏
996 ‎‡2 ISNI|0000000025259132‏
996 ‎‡2 BNF|12410408‏
996 ‎‡2 BNE|XX1316858‏
996 ‎‡2 BNE|XX861620‏
996 ‎‡2 LIH|LNB:B__L9;=_z_W‏
996 ‎‡2 LC|no 95016816‏
996 ‎‡2 BNCHL|10000000000000000138668‏
996 ‎‡2 LC|no2008010116‏
996 ‎‡2 DNB|1253142106‏
996 ‎‡2 BNE|XX4416704‏
996 ‎‡2 BNCHL|10000000000000000164411‏
996 ‎‡2 ISNI|0000000399460615‏
996 ‎‡2 DNB|1317939085‏
996 ‎‡2 BNE|XX1144954‏
996 ‎‡2 BNCHL|10000000000000000151509‏
996 ‎‡2 BNE|XX1097332‏
996 ‎‡2 DNB|140700455‏
996 ‎‡2 DBC|87097919233731‏
996 ‎‡2 BNE|XX1726872‏
996 ‎‡2 LC|no2021128359‏
996 ‎‡2 ISNI|0000000060170096‏
996 ‎‡2 BNF|16994599‏
996 ‎‡2 DNB|1151947938‏
996 ‎‡2 LC|n 93052973‏
996 ‎‡2 LC|n 89613851‏
996 ‎‡2 LC|n 2008022277‏
996 ‎‡2 LC|n 95005079‏
996 ‎‡2 BNE|XX4890428‏
996 ‎‡2 ARBABN|000069557‏
996 ‎‡2 BNE|XX1048851‏
996 ‎‡2 LC|n 00102897‏
996 ‎‡2 NSK|000478772‏
996 ‎‡2 BIBSYS|90781151‏
996 ‎‡2 ISNI|0000000060513319‏
996 ‎‡2 BNE|XX1075735‏
996 ‎‡2 LC|n 97117235‏
996 ‎‡2 LC|n 85189609‏
996 ‎‡2 JPG|500261606‏
996 ‎‡2 BNC|981058513889106706‏
996 ‎‡2 BNC|981058610367806706‏
996 ‎‡2 BNE|XX1040001‏
996 ‎‡2 BNE|XX991250‏
996 ‎‡2 PTBNP|201566‏
996 ‎‡2 LC|no2017030421‏
996 ‎‡2 BNE|XX1184795‏
996 ‎‡2 ISNI|0000000454231146‏
996 ‎‡2 SUDOC|031954987‏
996 ‎‡2 BNE|XX1093976‏
996 ‎‡2 SUDOC|072808691‏
996 ‎‡2 LC|no2017052827‏
996 ‎‡2 BNC|981058610501606706‏
996 ‎‡2 NTA|419576061‏
996 ‎‡2 ISNI|0000000072461720‏
996 ‎‡2 DNB|1168242037‏
996 ‎‡2 ISNI|000000043720199X‏
996 ‎‡2 ISNI|0000000081319662‏
996 ‎‡2 LC|n 2022057780‏
996 ‎‡2 BNE|XX1574990‏
996 ‎‡2 ISNI|000000003399003X‏
996 ‎‡2 ISNI|0000000047670256‏
996 ‎‡2 LC|no2002023419‏
996 ‎‡2 ISNI|0000000035409528‏
996 ‎‡2 BNE|XX5538758‏
996 ‎‡2 BNE|XX5017425‏
996 ‎‡2 NSK|000294506‏
996 ‎‡2 BNE|XX883497‏
996 ‎‡2 BIBSYS|59922‏
996 ‎‡2 BNF|16978156‏
996 ‎‡2 BNE|XX1220629‏
996 ‎‡2 ISNI|0000000116103141‏
996 ‎‡2 BNE|XX5399421‏
996 ‎‡2 SUDOC|267764111‏
996 ‎‡2 LC|ns2015000804‏
996 ‎‡2 ISNI|0000000059594932‏
996 ‎‡2 BNE|XX5457491‏
996 ‎‡2 RERO|A026623020‏
996 ‎‡2 SUDOC|228275245‏
996 ‎‡2 J9U|987011946174405171‏
996 ‎‡2 LC|n 88268638‏
996 ‎‡2 RERO|A003609015‏
996 ‎‡2 ISNI|0000000080172101‏
996 ‎‡2 ISNI|0000000059684022‏
996 ‎‡2 ISNI|0000000117789034‏
996 ‎‡2 LC|no2019094068‏
996 ‎‡2 BLBNB|001416727‏
996 ‎‡2 BNC|981058511881306706‏
996 ‎‡2 NUKAT|n 2008130772‏
996 ‎‡2 LC|no 91013866‏
996 ‎‡2 ISNI|0000000116426020‏
996 ‎‡2 BNE|XX5207781‏
996 ‎‡2 ISNI|0000000079787854‏
996 ‎‡2 SUDOC|147928869‏
996 ‎‡2 LC|n 96005202‏
996 ‎‡2 BNE|XX824965‏
996 ‎‡2 NUKAT|n 2012109200‏
996 ‎‡2 BNE|XX1402548‏
996 ‎‡2 LC|no 91026867‏
996 ‎‡2 DNB|1168908884‏
996 ‎‡2 DNB|1057488437‏
996 ‎‡2 ISNI|0000000385362942‏
996 ‎‡2 LC|n 87127727‏
996 ‎‡2 BNE|XX1351972‏
996 ‎‡2 DNB|1057665878‏
996 ‎‡2 BNE|XX1238466‏
996 ‎‡2 LC|no2008008811‏
996 ‎‡2 LC|no2005079333‏
996 ‎‡2 LC|no2004025970‏
996 ‎‡2 BNE|XX1163068‏
996 ‎‡2 LC|no2017058530‏
996 ‎‡2 ISNI|0000000047335722‏
996 ‎‡2 BNE|XX1633980‏
996 ‎‡2 LC|no2010033561‏
996 ‎‡2 PLWABN|9813180750605606‏
996 ‎‡2 ISNI|0000000042874399‏
996 ‎‡2 DNB|171390822‏
996 ‎‡2 ISNI|0000000059946176‏
996 ‎‡2 LC|n 95027086‏
996 ‎‡2 LC|no2017136121‏
996 ‎‡2 DNB|1056233613‏
996 ‎‡2 BNF|17970679‏
996 ‎‡2 NUKAT|n 2008114322‏
996 ‎‡2 NUKAT|n 2011171098‏
996 ‎‡2 LC|n 88143244‏
996 ‎‡2 SUDOC|03298779X‏
996 ‎‡2 ISNI|000000004492795X‏
996 ‎‡2 ISNI|0000000399052419‏
996 ‎‡2 DNB|1064905528‏
996 ‎‡2 BNE|XX1259817‏
996 ‎‡2 ISNI|0000000130316055‏
996 ‎‡2 LC|n 2022057797‏
996 ‎‡2 BNC|981058515541506706‏
996 ‎‡2 DNB|1057429627‏
996 ‎‡2 ISNI|0000000117554016‏
996 ‎‡2 ISNI|0000000024628901‏
996 ‎‡2 BNE|XX1025194‏
996 ‎‡2 SUDOC|156270366‏
996 ‎‡2 BNC|981058617050106706‏
996 ‎‡2 SUDOC|071403116‏
996 ‎‡2 LC|n 00110618‏
996 ‎‡2 BNC|981058514477006706‏
996 ‎‡2 RERO|A003608965‏
996 ‎‡2 ISNI|0000000025722297‏
996 ‎‡2 ISNI|0000000062361582‏
996 ‎‡2 BNF|17738453‏
996 ‎‡2 BNE|XX1567180‏
996 ‎‡2 DNB|1298134013‏
996 ‎‡2 LC|no2009150130‏
996 ‎‡2 SUDOC|156160447‏
996 ‎‡2 KRNLK|KAC202161684‏
996 ‎‡2 BNE|XX915174‏
996 ‎‡2 BNE|XX4710569‏
996 ‎‡2 BNE|XX1250903‏
996 ‎‡2 BNE|XX1106692‏
996 ‎‡2 BNC|981058510871406706‏
996 ‎‡2 ISNI|0000000060417028‏
996 ‎‡2 SUDOC|155304941‏
996 ‎‡2 BNE|XX4771203‏
996 ‎‡2 BNC|981058609065406706‏
996 ‎‡2 NII|DA15908142‏
996 ‎‡2 NUKAT|nx2022557009‏
996 ‎‡2 ARBABN|000069584‏
996 ‎‡2 BNC|981058515450806706‏
997 ‎‡a 1900 0 flourished 0000 0‏ ‎‡9 1‏
998 ‎‡a Sánchez-Moreno, José.‏ ‎‡2 NUKAT|n 2017046962‏ ‎‡3 exact title: (1.00, 'treatmentresistantbipolardepressiontowardsanewdefinition', 'treatmentresistantbipolardepressiontowardsanewdefinition')‏ ‎‡3 suggested‏ ‎‡3 viafid‏
998 ‎‡a Sánchez-Moreno, José‏ ‎‡2 BNE|XX4615594‏ ‎‡3 suggested‏